Live Breaking News & Updates on Douglase onsi

Stay informed with the latest breaking news from Douglase onsi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Douglase onsi and stay connected to the pulse of your community

Leap Therapeutics Announces $40 Million Private Placement

Leap Therapeutics Announces $40 Million Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , United-states , Matthew-deyoung , Douglase-onsi , Drug-administration , Prnewswire-leap-therapeutics-inc , Leap-therapeutics-inc , Exchange-commission , Nasdaq , Gilead-sciences-inc

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states , Cambridge , Cambridgeshire , United-kingdom , San-francisco , California , American , Matthew-deyoung , Meredith-pelster , Douglase-onsi , Zev-wainberg , Drug-administration

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...

San-francisco , California , United-states , Cambridge , Cambridgeshire , United-kingdom , American , Zev-wainberg , Douglase-onsi , Matthew-deyoung , Meredith-pelster , Drug-administration

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 3, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E....

San-francisco , California , United-states , Cambridge , Cambridgeshire , United-kingdom , Douglase-onsi , Matthew-deyoung , Nasdaq , Leap-therapeutics-inc , Leap-therapeutics , Chief-executive-officer

Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients

CAMBRIDGE, Mass. , Jan. 2, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that enrollment...

Cambridge , Cambridgeshire , United-kingdom , Cynthia-sirard , Douglase-onsi , Matthew-deyoung , Leap-therapeutics-inc , Nasdaq , Drug-administration , Leap-therapeutics , Chief-medical-officer , Annual-report

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tennessee , United-states , Cambridge , Cambridgeshire , United-kingdom , San-francisco , California , American , Douglase-onsi , Matthew-deyoung , Meredith-pelster , Msc-sarah-cannon-research-institute

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 21, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E....

New-york , United-states , Cambridge , Cambridgeshire , United-kingdom , Piper-sandler , Douglase-onsi , Prnewswire-leap-therapeutics-inc , Leap-therapeutics-inc , Nasdaq , Chief-executive-officer , Annual-healthcare-conference

Leap Therapeutics Reports Third Quarter 2023 Financial Results

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

Cambridge , Cambridgeshire , United-kingdom , Australia , China , Australian , Matthew-deyoung , Novarock-biotherapeutics , Douglase-onsi , Nasdaq , Drug-administration , Leap-therapeutics-inc

Leap Therapeutics to Participate at Upcoming Investor Conferences

Leap Therapeutics to Participate at Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Douglase-onsi , Matthew-deyoung , Leap-therapeutics-inc , Prnewswire-leap-therapeutics-inc , Nasdaq , Chief-executive-officer , Presentation-details , Annual-global-investment , Leap-therapeutics

Leap Therapeutics Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

United-states , Cambridge , Cambridgeshire , United-kingdom , Australia , China , Australian , American , Douglase-onsi , Matthew-deyoung , Novarock-biotherapeutics , Leap-therapeutics-inc